SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Value Creation Plan Crystallises

7 Jan 2013 07:00

RNS Number : 9097U
Gooch & Housego PLC
07 January 2013
 



For immediate release

7 January 2013

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Value Creation Plan Crystallises

 

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, announces that the Company's Value Creation Plan (VCP) crystallises today.

 

Further to the update issued on 4 October 2012, we are now able to provide details of the share option awards and share awards that will be made today. As a reminder, on 7 January 2010, following consultation with major shareholders, a share-based incentive scheme in the form of a VCP was put in place. At the same time approved share options were awarded under the Company Share Option Plan (CSOP) to UK-based participants. In accordance with the rules of the plan, on the third anniversary of the plan (today) the value created during the life of the plan, over and above a pre-determined threshold value based on a share price of £2.00, has been calculated and a share of that value (approximately 12%) will be distributed among the participating members of the senior management of the Company in the form of nil-cost share options (UK participants) and share awards (US participants). Half of the awards made today are exercisable immediately and the balance after twelve months, subject to certain conditions.

 

Details of the awards are as follows: -

 

Total number of market value CSOP share options awarded: 158,936

Total number of nil-cost share options and shares awarded: 1,380,566

 

In terms of dilutive effect, in aggregate these awards amount to 7% of the current issued share capital, although, as mentioned above, half the awards are not exercisable for twelve months.

 

Aggregate awards made to directors of the Company are as follows: -

 

Gareth Jones (CEO): 19,867 CSOP share options

450,747 Nil-cost share options

 

Terry Scribbins (COO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Andrew Boteler (CFO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Save for possibly some of the CSOP share options, the above directors are not planning to exercise any of their nil-cost options until June 2013 at the earliest.

 

For further information contact: -

 

Gareth Jones / Andrew Boteler

Gooch & Housego plc

01460 256440

Tim Thompson / Nicola Cronk

Buchanan

020 7466 5000

Patrick Robb/James Grace

Investec Bank plc

020 7597 5970

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNVUROAAARAR
Date   Source Headline
8th Feb 202110:20 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
7th Jan 202112:17 pmRNSGrant of LTIP Awards
23rd Dec 20207:00 amRNSLaunch of Satellite Laser Communication System
18th Dec 20207:00 amRNSPosting of Annual Report and AGM Notice
1st Dec 20207:00 amRNSPreliminary Results
16th Nov 20207:00 amRNSNotification of Full Year Results
6th Oct 20207:00 amRNSFull Year Trading Update
2nd Sep 20207:00 amRNSTrading Update
1st Sep 202012:07 pmRNSSecond Price Monitoring Extn
1st Sep 202012:02 pmRNSPrice Monitoring Extension
3rd Jun 20202:53 pmRNSDirector/PDMR Shareholding
2nd Jun 202011:37 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSInterim Results
18th May 20207:00 amRNSNotification of Half Year Results
11th May 20207:00 amRNSAppointment of Non-Executive Director
23rd Apr 20204:23 pmRNSHolding(s) in Company
9th Apr 20203:25 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSHalf Year Trading Update
27th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSUS Facilities Update
17th Mar 20201:22 pmRNSFremont Facility Update
16th Mar 20201:56 pmRNSDirector/PDMR Shareholding
6th Mar 20209:45 amRNSDirector Share Purchase
3rd Mar 20207:00 amRNSStreamlining of Manufacturing
19th Feb 202012:23 pmRNSResult of AGM
19th Feb 20207:00 amRNSAGM Trading Update
3rd Feb 202012:08 pmRNSIssue of Equity and Total Voting Rights
14th Jan 202010:21 amRNSGrant of LTIP Awards
27th Dec 20193:26 pmRNSDirectorate: David Bauernfeind
11th Dec 20197:00 amRNSPosting of Annual Report and AGM Notice
9th Dec 20198:50 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSPreliminary Results
20th Nov 20198:42 amRNSBlock listing Interim Review
15th Nov 20194:41 pmRNSSecond Price Monitoring Extn
15th Nov 20194:35 pmRNSPrice Monitoring Extension
11th Nov 201911:18 amRNSConfirmation of Directorate Change
8th Nov 201912:54 pmRNSTotal Voting Rights
7th Oct 20197:00 amRNSFull Year Trading Update and Results Notification
6th Aug 201912:02 pmRNSPrice Monitoring Extension
18th Jul 201910:11 amRNSChief Financial Officer Appointment Timing Update
1st Jul 201910:57 amRNSDirector/PDMR Shareholding
6th Jun 201912:58 pmRNSDirector Share Purchase
4th Jun 20194:23 pmRNSDirectors' Share Purchases
4th Jun 20197:00 amRNSDirectorate Change
4th Jun 20197:00 amRNSInterim Results
28th May 20199:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.